Skip to main content
. 2024 May 9;10(10):e31003. doi: 10.1016/j.heliyon.2024.e31003

Table 2.

Distribution of the MTHFR C677T polymorphism in the END and Non-END Groups Under Different Genetic Models.

Genetic models Distribution(n, %)
Unadjusted
Adjusteda
END
n = 129)
Non-END
n = 305)
OR 95%CI P_value OR 95%CI P_value
Allelic model
 T 139 (53.9) 259 (42.5) 1.583 1.181–2.121 0.002
 C 119 (46.1) 351 (57.7)
Genotype
 TT 40 (31.0) 56 (18.4)
 CT 59 (45.7) 147 (48.2)
 CC 30 (23.3) 102 (33.4)
Dominant model
CC 30 (23.3) 102 (33.4) 0.603 0.376–0.968 0.035 0.748 0.440–1.272 0.284
 TT + CT 99 (76.7) 203 (66.6)
Recessive model
 TT 40 (31.0) 56 (18.4) 1.998 1.246–3.205 0.004 1.710 1.021–2.863 0.042
 CC + CT 89 (69.0) 249 (81.6)

Notes: END: early neurological deterioration; OR: odds ratio; 95%CI: 95%confidence interval; aOriginal values of unadjusted covariates.

a

Logistic multiple regression analysis results (adjusted variables: sex, age, WBC abnormality, drinking, smoking, diabetes history, HHcy, admission hyperglycemia, and NIHSS >5).